Docetaxel rechallenge was associated with longer OS and time to subsequent treatment or death compared with cabazitaxel for patinets with chemonaïve mCRPC.

Experts project the diagnosis of over 300,000 prostate cancer cases in the United States in 2006, along with over 30,000 ...

PRESS RELEASE AB SCIENCE RECEIVES NOTICE OF ALLOWANCE FOR UNITED STATES PATENT COVERING MASITINIB IN THE TREATMENT OF METASTATIC CASTRATE RESISTANT PROSTATE CANCER THIS POSITIVE DECISION FROM THE USA ...

At the San Antonio Breast Cancer Symposium, researchers discussed how results from HER2CLIMB-05 may inform first-line ...

Prostate cancer (PCa) remains a significant global health challenge, with rising morbidity rates and poor prognosis associated with advanced stages ...

Cardio-oncologists should incorporate vascular prevention in their care, especially for those without protective hormones.

AstraZeneca Pharma, in an exchange filing, said it has received the CDSCO's permission to import for sales and distribution of the solution for infusion 120 mg/2.4 ml and 500mg/10 ml for an additional ...

ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced positive results from its ANKTIVA ...

The Law of Mass action predicts that all adverse drug reactions are related to the concentration of the drug at the site of ...

Stocks like Sun Pharmaceutical, Bajaj Auto, GAIL India, NTPC, Jindal Steel, Bank of Baroda, Affle 3i, Delhivery, IDFC First ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

This episode of Treating Together, hosted by Chandler Park, MD, featuring guests Benjamin Garmezy, MD, and Manoj Bupathi, MD, ...